Luminous Mind Inc. is a pharmaceutical company focused on developing innovative treatments for Central Nervous System (CNS) disorders, including depression, PTSD, pain, anxiety, and addiction. The company employs a rigorous therapeutic discovery and development process, utilizing groundbreaking scientific insights in neuroscience, genetics, and systems biology, along with advanced tools like Artificial Intelligence (AI). Their approach includes repurposing existing drugs and developing patented New Chemical Entities (NCEs). With a multi-disciplinary team boasting over 100 years of CNS drug experience, Luminous Mind is building a diverse pipeline of therapeutics aimed at significantly improving neuropsychiatric care and addressing major medical challenges globally.
Something looks off?